Related content

A comparative study of breast cell proliferation during hormone replacement therapy: effects of tibolone and continuous combined estrogen-progestogen treatment

By Conner P.   Christow A.   Kersemaekers W.   Söderqvist G.   Skoog L.   Carlström K.   Tani E.   Mol-Arts M.   Schoultz B. von  

Climacteric, Vol. 7, Iss. 1, 2004-01 ,pp. : 50-58

Informa Healthcare

Access to resources Recommend Favorite

Influences of stroma-derived growth factors on the cytokine expression pattern of human breast cancer cell lines

By Hirtenlehner K.   Pec M.   Kubista E.   Singer C. F.  

Archives of Gynecology and Obstetrics, Vol. 266, Iss. 2, 2002-04 ,pp. : 108-113

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition

By Mueck A. O.   Seeger H.   Wallwiener D.  

Climacteric, Vol. 6, Iss. 3, 2003-09 ,pp. : 221-227

Informa Healthcare

Access to resources Recommend Favorite

Effects of fulvestrant alone or combined with different steroids in human breast cancer cells in vitro

By Jansen G. H.   Franke H. R.   Wolbers F.   Brinkhuis M.   Vermes I.  

Climacteric, Vol. 11, Iss. 4, 2008-01 ,pp. : 315-321

Informa Healthcare

Access to resources Recommend Favorite

Two case reports of ovarian cancer after long-term tamoxifen treatment for breast cancer

By Ohara N.   Kobayashi A.  

Journal of Obstetrics & Gynaecology, Vol. 22, Iss. 5, 2002-09 ,pp. : 572-573

Informa Healthcare

Access to resources Recommend Favorite